Abstract
Introduction Cirrhosis epidemiology is changing over the years with increase of NASH-related cirrhosis ad reduction of virus related cirrhosis. Since 2014, the introduction of Direct-acting antivirals (DAAs) modified the prognosis HCV-related cirrhosis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
